Also in bladder cancer, CpdA was reported to inhibit cell proliferation and induce cell cycle arrest and apoptosis in GR+/AR+ cells, and to reduce tumor growth more strongly than Dex in a xenograft model [37]. This evidence concerns the gene NR3C1 and neoplasm.